Agios Pharma (AGIO) PT Raised to $90 at RBC Capital
RBC Capital raised its price target on Agios Pharma (NASDAQ: AGIO) to $90.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
